Page last updated: 2024-08-26

beauvericin and EHS Tumor

beauvericin has been researched along with EHS Tumor in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Colvin, KL; Cook, JL; Routes, BA; Routes, JM; Walker, TA	1

Other Studies

1 other study(ies) available for beauvericin and EHS Tumor

Article	Year
E1A oncogene induction of cellular susceptibility to killing by cytolytic lymphocytes through target cell sensitization to apoptotic injury. Experimental cell research, 1999, Sep-15, Volume: 251, Issue:2 Topics: 3T3 Cells; Adenovirus E1A Proteins; Adenoviruses, Human; Animals; Anti-Bacterial Agents; Apoptosis; Cell Death; Cell Transformation, Viral; Cricetinae; Cytotoxicity, Immunologic; Depsipeptides; E1A-Associated p300 Protein; Humans; Killer Cells, Natural; Mice; Mutation; Necrosis; Nuclear Proteins; Peptides; Rats; Sarcoma, Experimental; Trans-Activators	1999

Article

Year

E1A oncogene induction of cellular susceptibility to killing by cytolytic lymphocytes through target cell sensitization to apoptotic injury.

Experimental cell research, 1999, Sep-15, Volume: 251, Issue:2

Topics: 3T3 Cells; Adenovirus E1A Proteins; Adenoviruses, Human; Animals; Anti-Bacterial Agents; Apoptosis; Cell Death; Cell Transformation, Viral; Cricetinae; Cytotoxicity, Immunologic; Depsipeptides; E1A-Associated p300 Protein; Humans; Killer Cells, Natural; Mice; Mutation; Necrosis; Nuclear Proteins; Peptides; Rats; Sarcoma, Experimental; Trans-Activators

1999